Chamber and committees

Scottish Ministers are fully committed to ending the practice of sending biodegradable municipal waste to landfill by 2025, in line with recommendations made by the Committee on Climate Change. By working to achieve our ambitious waste and recycling targets, we can ensure a transition to a fully circular economy and help to achieve our net zero commitments.

The implementation of the ban was delayed to 2025 to allow local authorities and the wider waste sector the necessary time to ensure full readiness and avoid unintended negative economic impacts, as highlighted by the Waste Markets Study (2019) . We are working to provide a centrally supported procurement solution to help local authorities secure alternative solutions to comply with the forthcoming ban. In addition, we will continue to engage with the commercial sector to support their preparation and input in to the delivery of the ban.

We recognise that the actions needed to become net zero by 2045 will transform all sectors of our economy and society. The Scottish Government is committed to a just transition, which is about ensuring that, as we reduce our emissions and respond to a changing climate, that journey is fair and creates a better future for everyone – regardless of where they live, what they do, and who they are. We are working with industry and businesses to maximise the opportunities and realise the benefits of a circular economy, identifying where there are opportunities to make transformational changes. We will ensure our transition to net-zero creates new opportunities for people across the country. For example, we are investing £100 million in the Green Jobs Fund which will provide support to businesses (and their supply chains) to help them better transition to a low carbon economy. In so doing, the Green Jobs Fund will boost green employment and create opportunities for individuals to retrain and upskill in new and high-growth areas.

To understand the effectiveness of the COVID-19 vaccines in preventing the development of long COVID, an individual first has to have had COVID-19 in the first place.

Therefore, the question really is effectiveness of vaccines in preventing the COVID-19 virus and subsequent long COVID. A study published by Public Health England on 22 May 2021, Vaccines highly effective against B.1.617.2 variant after 2 doses , demonstrates the high effectiveness levels of two doses of both AstraZeneca and Pfizer vaccines against the Delta variant.

Two doses offer good protection against the Delta variant at levels of 88% and 60% for Pfizer and AstraZeneca vaccines respectively after two weeks. This is compared to 93% and 66% against the Kent variant. One dose of either vaccine offers protection of 33% against Delta variant after three weeks, compared to 50% against the Kent variant.

This follows data published on 23 April 2021 by the University of Oxford and the Office for National Statistics which showed that one dose of either the Pfizer or AstraZeneca cut coronavirus cases by nearly two-thirds and were 74% effective against symptomatic infection.

Clinical trials have found that vaccination against COVID-19 further reduces the likelihood contracting long COVID even if an individual develops COVID-19. A paper published by the Tony Blair Institute on 18 June 2021, The Hidden Pandemic: Long Covid , states ‘vaccination also provides additional protection against long COVID: even if a vaccinated individual goes on to contract Covid-19, that person’s chances of developing Long Covid are reduced by a further 30 per cent in the most at-risk age group.’

Additionally, the vaccines have shown to also relieve symptoms of long COVID in people that already developed COVID-19. Yale School of Medicine stated on 12 April 2021, Why Vaccines May Be Helping Some With Long COVID , ‘as many as 30 to 40 per cent of those who get the vaccine have reported improvements to their symptoms.’

However, analysis by Professor Karl Friston, of University College London, suggests that changes in people’s behaviour after being vaccinated have reduced the vaccines’ ability to prevent infection . People who have “let their guards down” by dramatically reducing social distancing and other safety measures have put themselves at much higher risk of contracting COVID -19 and potentially developing long COVID, believes Professor Friston, who publishes a weekly Covid-modelling report and sits on the influential independent Scientific Advisory Group for Emergencies ( SAGE ).

The Young Person’s Guarantee – Implementation Progress Report was published on 28 July and outlines the progress made against each of the initial recommendations within Youth Guarantee - No-one Left Behind: initial report, published on 2 September 2020. The progress report also provides an outline of the next steps against the commitments made in the supporting Activity Plan and is accompanied by the Key Performance Indicators, which are part of the broader Measurement and Evaluation Framework underpinning the Young Person’s Guarantee. The Framework will support our understanding of the impact of the Young Person’s Guarantee across a range of economic, education and equalities outcomes, enabling the targeting of future resource and to ensure that no young person is left behind.

As Minister for Higher Education, Further Education, Youth Employment and Training, I will be leading this work, alongside Sandy Begbie, partners and stakeholders to continue to build on progress to tackle youth unemployment and to improve the life chances of young people. This includes the delivery of relevant manifesto commitments contained within First Steps , which are to:

• Appoint a Minister specifically tasked with supporting youth employment;
• Invest £45 million through local partnerships to provide training and employer recruitment incentives;
• Fund colleges to deliver around 5,000 more short, industry-focussed courses to help young people train for jobs in key industries;
• Roll-out new school coordinators across the country to support young people access education, work, or training; and,
• Establish a new graduate internship scheme and increase places on volunteering and third sector programmes.

Scottish Government officials regularly meet with Alcohol and Drug Partnerships which allows for discussion on a wide range of issues as part of our shared commitment to reduce drug deaths.

Meetings with officials have taken place in May, June and July 2021. Most recently I met with Cathie Cowan, CEO of NHS Forth Valley, on 6 July discussing drug deaths, MAT implementation, Buvidal and workforce culture. I also met with Carol Chamberlain, Strategic Lead for South Lanarkshire ADP, on Wednesday 23 June as part of a joint meeting with stakeholders to discuss residential rehabilitation.

The next meeting with all ADPs is scheduled to take place in August 2021 and will focus on funding the national mission to reduce drugs deaths.

Whilst a specific date cannot be given for the publication of the NHS Recovery Plan at this time the Scottish Government have committed to publishing this plan within the first hundred days of the new parliament.

The NHS Recovery Plan will set out our plans to increase inpatient, day case, and outpatient activity by 10% supported by the implementation of sustainable improvements and new models of care.

As part of this, the Finance Secretary announced an additional £60 million earlier this year to help NHS boards address the pandemic induced backlog and remobilise services.

While further details are still being developed, the Plan will:

• Ensure patients who have been impacted by the pause in services receive access to the care they require.
• Improve patient pathways from primary through to secondary care – engagement with stakeholders and patients will be key to delivering this.
• Put in place additional staff to meet anticipated increase in hospital activity and new ways of working.
• Further invest in a network of National Treatment Centres which will provide additional capacity for elective care.

This question relates to operational matters that are the responsibility of the Scottish Court and Tribunals Service (SCTS) corporate body. The question has been passed to the Chief Executive of the SCTS who will reply in writing within 20 days

The Scottish Government is committed to improving the lives of trans and non-binary people in Scotland. Trans people continue to suffer poorer outcomes relative to the wider population, and this needs to change.

We are committed to ensuring that all children and young people are supported in school and are able to reach their full potential, including transgender young people. We committed to develop guidance to support schools to do this and will publish guidance shortly.

The agreement announced recently between the Scottish Government and COSLA will see the Scottish Government provide funding in the 2021-22 academic year to allow current levels of provision in local authorities to be sustained at no cost to families.

The Scottish Government is committed to working with local authorities to establish a sustainable approach to the service and to funding for future years.

Changes to travel restrictions affecting Manchester City Council and Salford City Council were notified to Parliament by answer to question
S6W-00856 on 17 June 2021, and announced to businesses and the public through a media briefing by the First Minister, a news release, and updated guidance on the Scottish Government website. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Scottish Government is committed to introducing new and innovative treatment practices to address problem substance use, based on strong and sufficient evidence.

We have had discussions with a number of external stakeholders as well as internal policy and analytical teams to help inform our position on NET. As a result of these discussions we were advised that before Neuro-Electric Therapy (NET) could be made available as a treatment option through the NHS, it must be researched according to current guidelines and NHS ethics and be registered, as a licensed medical device, with Medicines & Healthcare products Regulatory Agency ( MHRA). Until this happens the device can only be used in experiments or medical trials.

These discussions also concluded that as Scottish Government does not directly fund clinical trials or literature reviews into the efficacy of specific treatment interventions, we should recommend that NET RECOVERY Corporation- the company that manufactures NET device - should explore funding streams available through a number of open and competitive funding channels including Medical Research Council and the CMOs Chief Scientist Office.